BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
3/22/2022 4:46:09 AM | Browse: 223 | Download: 387
 |
Received |
|
2021-08-07 16:29 |
|
Peer-Review Started |
|
2021-08-07 16:33 |
 |
To Make the First Decision |
|
|
|
Return for Revision |
|
2021-11-11 09:09 |
|
Revised |
|
2021-11-22 18:26 |
|
Second Decision |
|
2022-02-22 03:28 |
|
Accepted by Journal Editor-in-Chief |
|
|
|
Accepted by Company Editor-in-Chief |
|
2022-02-23 21:11 |
|
Articles in Press |
|
2022-02-23 21:11 |
|
Publication Fee Transferred |
|
|
|
Edit the Manuscript by Language Editor |
|
2022-02-21 04:56 |
|
Typeset the Manuscript |
|
2022-03-21 01:53 |
|
Publish the Manuscript Online |
|
2022-03-22 04:46 |
| ISSN |
2220-3249 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2022. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Pharmacology & Pharmacy |
| Manuscript Type |
Letter to the Editor |
| Article Title |
Therapeutic potential of N-acetyl cysteine during COVID-19 epoch
|
| Manuscript Source |
Unsolicited Manuscript |
| All Author List |
Ajita Kapur, Munish Sharma and Geetanjali Sageena |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Geetanjali Sageena, PhD, Assistant Professor, Environmental Studies, Keshav Mahavidyalaya University of Delhi, H-4-5 Zone Pitampura, New Delhi 110034, India. geetanjali.sageena@keshav.du.ac.in |
| Key Words |
N-acetyl cysteine; COVID-19; Coagulopathy; Therapeutic potential |
| Core Tip |
Risk of coagulopathy is noteworthy in coronavirus disease 2019 (COVID-19) and cerebral haemorrhage could be a potential risk in COVID-19 patients receiving N-acetyl cysteine (NAC). Results of well-designed randomized controlled trials should be awaited before NAC becomes a common practice for prophylaxis and treatment of patients with COVID-19. |
| Publish Date |
2022-03-22 04:46 |
| Citation |
Kapur A, Sharma M, Sageena G. Therapeutic potential of N-acetyl cysteine during COVID-19 epoch. World J Virol 2022; 11(2): 104-106 |
| URL |
https://www.wjgnet.com/2220-3249/full/v11/i2/104.htm |
| DOI |
https://dx.doi.org/10.5501/wjv.v11.i2.104 |
© 2004-2024 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345
